New drugs in the US were, on average, approved months before winning approval in the EU, according to new data from The IQVIA Institute for …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment
Behavioral changes through technology-supported interventions could help reduce sodium intake and positively impact health.
Digital breast tomosynthesis (DBT) screening supplemented by MRI for women with dense breasts led to both greater benefits and increased harms in a model-based comparative